BHARAT PARENTERALS
|
The Current P/E Ratio of BHARAT PARENTERALS is -19.45.
Share Price | ₹1,037.3 | May 05,2025 |
Market Cap | ₹715.7 Cr | |
Earnings-TTM | ₹-36.8 Cr | TTM-Consolidated Results |
Price/Earnings | -19.45x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BHARAT PARENTERALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹715.7 Cr] as on May 05,2025
(/) Earnings [ ₹-36.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -19.45x ]
Thus, for BHARAT PARENTERALS , the investors are currently willing to pay -19.45 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BHARAT PARENTERALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BHARAT PARENTERALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BHARAT PARENTERALS
PE Ratio Performance Analysis for BHARAT PARENTERALS
- BHARAT PARENTERALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 15.79x.
- BHARAT PARENTERALS 's operated at median p/e ratio of 9.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT PARENTERALS 's p/e ratio peaked in Mar2024 at 44.99x.
- BHARAT PARENTERALS 's p/e ratio hit its five-year low in Mar2020 of 3.37x.
How does BHARAT PARENTERALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BHARAT PARENTERALS | -36.79 | -19.45 | 715.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 38.33 | 440,314.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.77 | 162,809.0 |
CIPLA LTD | 5,000.43 | 24.92 | 124,627.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.68 | 111,127.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.02 | 97,839.9 |
MANKIND PHARMA LTD | 2,050.73 | 48.61 | 99,679.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.55 | 89,771.2 |
LUPIN LTD | 2,892.10 | 32.96 | 95,309.6 |
AUROBINDO PHARMA LTD | 3,500.25 | 20.62 | 72,176.2 |
ABBOTT INDIA LTD | 1,334.46 | 49.00 | 65,394.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BHARAT PARENTERALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -19.45x |
Max industry PE | 78.77x |
Median industry PE | 32.96x |
Average industry PE | 33.73x |
You may also like the below Video Courses